Published in TZ Latest News
20 December, 2021 by The TZ Newswire Staff
Cytokinetics and JI XING Announce Expansion of Collaboration to Include Licensing of Omecamtiv Mecarbil in China; RTW to Add to Its Investment in Cytokinetics
JI XING to Develop and Commercialize Novel Cardiac Myosin Activator in Patients with Heart Failure